Da An Gene Co Ltd of Sun Yat-Sen University (002030) - Total Assets
Based on the latest financial reports, Da An Gene Co Ltd of Sun Yat-Sen University (002030) holds total assets worth CN¥8.33 Billion CNY (≈ $1.22 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can Da An Gene Co Ltd of Sun Yat-Sen Univers service its debt to assess how comfortably operating cash covers total debt obligations.
Da An Gene Co Ltd of Sun Yat-Sen University - Total Assets Trend (2001–2025)
This chart illustrates how Da An Gene Co Ltd of Sun Yat-Sen University's total assets have evolved over time, based on quarterly financial data. See 002030 total equity for net asset value and shareholders' equity analysis.
Da An Gene Co Ltd of Sun Yat-Sen University - Asset Composition Analysis
Current Asset Composition (December 2025)
Da An Gene Co Ltd of Sun Yat-Sen University's total assets of CN¥8.33 Billion consist of 33.4% current assets and 66.6% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 6.0% |
| Accounts Receivable | CN¥745.54 Million | 8.8% |
| Inventory | CN¥147.58 Million | 1.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥655.84 Million | 7.7% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2001–2025)
This chart illustrates how Da An Gene Co Ltd of Sun Yat-Sen University's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 002030 company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Da An Gene Co Ltd of Sun Yat-Sen University's current assets represent 33.4% of total assets in 2025, a decrease from 41.9% in 2001.
- Cash Position: Cash and equivalents constituted 6.0% of total assets in 2025, down from 22.4% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 0.0% in 2001.
- Asset Diversification: The largest asset category is accounts receivable at 8.8% of total assets.
Da An Gene Co Ltd of Sun Yat-Sen University Competitors by Total Assets
Key competitors of Da An Gene Co Ltd of Sun Yat-Sen University based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Verona Pharma plc
F:I9SA
|
Germany | €572.87 Million |
|
Xiamen Amoytop Biotech Co Ltd
SHG:688278
|
China | CN¥3.21 Billion |
|
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
|
USA | $472.67 Million |
|
Neuren Pharmaceuticals Ltd
AU:NEU
|
Australia | AU$331.25 Million |
|
Vor Biopharma Inc
NASDAQ:VOR
|
USA | $506.75 Million |
|
Chengdu Kanghua Biological Products
SHE:300841
|
China | CN¥3.94 Billion |
|
Jiangsu Aidea Pharmaceutical Co Ltd
SHG:688488
|
China | CN¥1.84 Billion |
Da An Gene Co Ltd of Sun Yat-Sen University - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.98 | 2.91 | 2.65 |
| Quick Ratio | 2.82 | 2.74 | 2.41 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.86 Billion | CN¥2.17 Billion | CN¥3.21 Billion |
Da An Gene Co Ltd of Sun Yat-Sen University - Advanced Valuation Insights
This section examines the relationship between Da An Gene Co Ltd of Sun Yat-Sen University's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.99 |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | -11.1% |
| Total Assets | CN¥8.51 Billion |
| Market Capitalization | $1.14 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Da An Gene Co Ltd of Sun Yat-Sen University's assets below their book value (0.13x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Da An Gene Co Ltd of Sun Yat-Sen University's assets decreased by 11.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Da An Gene Co Ltd of Sun Yat-Sen University (2001–2025)
The table below shows the annual total assets of Da An Gene Co Ltd of Sun Yat-Sen University from 2001 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥8.51 Billion ≈ $1.25 Billion |
-11.14% |
| 2024-12-31 | CN¥9.58 Billion ≈ $1.40 Billion |
-13.08% |
| 2023-12-31 | CN¥11.02 Billion ≈ $1.61 Billion |
-25.34% |
| 2022-12-31 | CN¥14.76 Billion ≈ $2.16 Billion |
+42.77% |
| 2021-12-31 | CN¥10.34 Billion ≈ $1.51 Billion |
+54.27% |
| 2020-12-31 | CN¥6.70 Billion ≈ $980.42 Million |
+88.12% |
| 2019-12-31 | CN¥3.56 Billion ≈ $521.18 Million |
-2.78% |
| 2018-12-31 | CN¥3.66 Billion ≈ $536.06 Million |
-21.08% |
| 2017-12-31 | CN¥4.64 Billion ≈ $679.24 Million |
+12.13% |
| 2016-12-31 | CN¥4.14 Billion ≈ $605.76 Million |
+36.10% |
| 2015-12-31 | CN¥3.04 Billion ≈ $445.10 Million |
+91.28% |
| 2014-12-31 | CN¥1.59 Billion ≈ $232.70 Million |
+37.66% |
| 2013-12-31 | CN¥1.16 Billion ≈ $169.04 Million |
+26.63% |
| 2012-12-31 | CN¥912.28 Million ≈ $133.50 Million |
+16.17% |
| 2011-12-31 | CN¥785.29 Million ≈ $114.91 Million |
+16.55% |
| 2010-12-31 | CN¥673.75 Million ≈ $98.59 Million |
+15.14% |
| 2009-12-31 | CN¥585.17 Million ≈ $85.63 Million |
+10.43% |
| 2008-12-31 | CN¥529.90 Million ≈ $77.54 Million |
+24.43% |
| 2007-12-31 | CN¥425.87 Million ≈ $62.32 Million |
+30.60% |
| 2006-12-31 | CN¥326.08 Million ≈ $47.72 Million |
+9.85% |
| 2005-12-31 | CN¥296.85 Million ≈ $43.44 Million |
-5.15% |
| 2004-12-31 | CN¥312.97 Million ≈ $45.80 Million |
+77.39% |
| 2003-12-31 | CN¥176.43 Million ≈ $25.82 Million |
+35.15% |
| 2002-12-31 | CN¥130.54 Million ≈ $19.10 Million |
+30.92% |
| 2001-12-31 | CN¥99.71 Million ≈ $14.59 Million |
-- |
About Da An Gene Co Ltd of Sun Yat-Sen University
Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through two segments, Biological Products and Related Business and Financial Business. The company offers reagents for hepatitis virus, sexually transmitted infections, blood screening, digestive pathogens, coro… Read more